|
|
Previous Article | Table of Contents | Next Article 
Interleukin-10 inhibits activation of coagulation and fibrinolysis during
human endotoxemia
D Pajkrt, T van der Poll, M Levi, DL Cutler, MB Affrime, A van den Ende, JW ten Cate and SJ van Deventer
Laboratory of Experimental Internal Medicine and Center for Hemostasis,
Thrombosis, Atherosclerosis and Inflammation Research, Academic Medical
Center, University of Amsterdam, The Netherlands.
Interleukin-10 (IL-10) has been found to inhibit lipopolysaccharide
(LPS)-induced tissue factor expression by monocytes in vitro. To determine
the effects of IL-10 on LPS-induced activation of the hemostatic mechanisms
in vivo, we performed a placebo-controlled, cross- over study of human
endotoxemia. Two groups of eight volunteers were challenged with LPS (4
ng/kg) on two occasions: once in conjunction with placebo, and once with
recombinant human IL-10 (rhIL-10; 25 microg/kg). In group 1, placebo or
rhIL-10 was given 2 minutes before LPS challenge, group 2 received placebo
or rhIL-10 1 hour after LPS administration. Pretreatment with rhIL-10
reduced both LPS-induced activation of the fibrinolytic system (plasma
concentrations of tissue type plasminogen activator,
plasmin-alpha2-antiplasmin complexes, and D- dimer), and inhibition of
fibrinolysis (plasma levels of plasminogen activator inhibitor 1), whereas
posttreatment only inhibited the latter response. Both IL-10 pre- and
posttreatment attenuated activation of the coagulation system (plasma
levels of prothrombin fragment F1 + 2 and thrombin-antithrombin complexes).
These results indicate that rhIL- 10, besides its well-described inhibitory
effects on cytokine release, potently modulates the fibrinolytic system and
inhibits the coagulant responses during endotoxemia.
Volume 89,
Issue 8,
pp. 2701-2705,
04/15/1997
Copyright © 1997 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. Tamassia, F. Calzetti, N. Menestrina, M. Rossato, F. Bazzoni, L. Gottin, and M. A. Cassatella
Circulating neutrophils of septic patients constitutively express IL-10R1 and are promptly responsive to IL-10
Int. Immunol.,
April 1, 2008;
20(4):
535 - 541.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bahador and A. S. Cross
Review: From therapy to experimental model: a hundred years of endotoxin administration to human subjects
Innate Immunity,
October 1, 2007;
13(5):
251 - 279.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Garantziotis, D. M. Brass, J. Savov, J. W. Hollingsworth, E. McElvania-TeKippe, K. Berman, J. K. L. Walker, and D. A. Schwartz
Leukocyte-Derived IL-10 Reduces Subepithelial Fibrosis Associated with Chronically Inhaled Endotoxin
Am. J. Respir. Cell Mol. Biol.,
December 1, 2006;
35(6):
662 - 667.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. T Keller, A. T.A Mairuhu, M. D de Kruif, S. K Klein, V. E.A Gerdes, H. ten Cate, D. P.M Brandjes, M. Levi, and E. C.M van Gorp
Infections and endothelial cells
Cardiovasc Res,
October 15, 2003;
60(1):
40 - 48.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Asadullah, W. Sterry, and H. D. Volk
Interleukin-10 Therapy--Review of a New Approach
Pharmacol. Rev.,
June 1, 2003;
55(2):
241 - 269.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. van der Poll
Coagulation and inflammation
Innate Immunity,
August 1, 2001;
7(4):
301 - 304.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. A. M. Dias, A. R. Goodman, J. L. Dos Santos, R. N. Gomes, A. Altmeyer, P. T. Bozza, M. de Fatima Horta, J. Vilcek, and L. F. L. Reis
TSG-14 transgenic mice have improved survival to endotoxemia and to CLP-induced sepsis
J. Leukoc. Biol.,
June 1, 2001;
69(6):
928 - 936.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Gerber and D. M. Mosser
Reversing Lipopolysaccharide Toxicity by Ligating the Macrophage Fc{{gamma}} Receptors
J. Immunol.,
June 1, 2001;
166(11):
6861 - 6868.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Peng, D. M. Mosser, M. W. Adler, T. J. Rogers, J. J. Meissler Jr, and T. K. Eisenstein
Morphine enhances interleukin-12 and the production of other pro-inflammatory cytokines in mouse peritoneal macrophages
J. Leukoc. Biol.,
November 1, 2000;
68(5):
723 - 728.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
F. N. Lauw, D. Pajkrt, C. E. Hack, M. Kurimoto, S. J. H. van Deventer, and T. van der Poll
Proinflammatory Effects of IL-10 During Human Endotoxemia
J. Immunol.,
September 1, 2000;
165(5):
2783 - 2789.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. F. Franco, E. de Jonge, P. E. P. Dekkers, J. J. Timmerman, C. A. Spek, S. J. H. van Deventer, P. van Deursen, L. van Kerkhoff, B. van Gemen, H. ten Cate, et al.
The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation
Blood,
July 15, 2000;
96(2):
554 - 559.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. R. HUANG, A. R. KITCHING, P. G. TIPPING, and S. R. HOLDSWORTH
Interleukin-10 Inhibits Macrophage-Induced Glomerular Injury
J. Am. Soc. Nephrol.,
February 1, 2000;
11(2):
262 - 269.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Ding, L. Qin, S. V. Kotenko, S. Pestka, and J. S. Bromberg
A Single Amino Acid Determines the Immunostimulatory Activity of Interleukin 10
J. Exp. Med.,
January 17, 2000;
191(2):
213 - 224.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. J. Elenkov, E. Webster, D. A. Papanicolaou, T. A. Fleisher, G. P. Chrousos, and R. L. Wilder
Histamine Potently Suppresses Human IL-12 and Stimulates IL-10 Production via H2 Receptors
J. Immunol.,
September 1, 1998;
161(5):
2586 - 2593.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Downing, R. M. Strieter, A. M. Kadell, C. A. Wilke, J. C. Austin, B. D. Hare, M. D. Burdick, L. J. Greenfield, and T. W. Wakefield
IL-10 Regulates Thrombus-Induced Vein Wall Inflammation and Thrombosis
J. Immunol.,
August 1, 1998;
161(3):
1471 - 1476.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Okada, T. Fujita, K. Minamoto, H. Liao, Y. Naka, and D. J. Pinsky
Potentiation of Endogenous Fibrinolysis and Rescue from Lung Ischemia/Reperfusion Injury in Interleukin (IL)-10-reconstituted IL-10 Null Mice
J. Biol. Chem.,
July 7, 2000;
275(28):
21468 - 21476.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|